Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients-Reference-Cited by-同舟云学术

Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients

Published:2023-07 Issue:7 Volume:29 Page:835-844
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Hu Fei-Hong,Jia Yi-Jie,Zhao Dan-Yan,Fu Xue-Lei,Zhang Wan-Qing,Tang Wen,Hu Shi-Qi,Wu Hua,Ge Meng-Wei,Du Wei,Shen Wang-Qin,Zhu Bin,Chen Hong-Lin

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference63 articles.

1. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study;Graham;Lancet Public Health,2021

2. Confronting the Delta variant of SARS-CoV-2, summer 2021;Del Rio;JAMA,2021

3. Delta variant triggers new phase in the pandemic;Kupferschmidt;Science,2021

4. Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China;Wang;EClinicalMedicine,2021

5. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum;Liu;Cell,2021

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Molnupiravir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study);2024-09-09

2. Epidemiological Features of the COVID-19 and Characteristics of Patients during the Spread of the Omicron SARS-COV-2 in Russia;Epidemiology and Vaccinal Prevention;2024-09-09

3. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period;Journal of Infection and Chemotherapy;2024-09

4. Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study);2024-07-01

5. Clinical Microbiology and Infection: how did we do in 2023?;Clinical Microbiology and Infection;2024-07